Global Recombinant Proteins Market Size, Share, Trends, Demand, Growth and Competitive Analysis 2030
The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape.
In-Depth Market Overview of Global
Recombinant Proteins Market (2024-2030):
According
to the latest report, the Global Recombinant
Proteins Market size is estimated to grow at a CAGR of around
7.4% during the forecast period, i.e., 2024-30. The
report demonstrates the prominent factors propelling the exponential growth of
the Global Recombinant Proteins Market.
Key Takeaways: Beneficial for
Stakeholders and Clients
·
Historic Period: 2019-2022
·
Base year: 2023
·
Forecast Years: 2024-2030
·
CAGR (2024-30): 7.4%
Key Perks: “In
case you missed it, we are currently revising our reports. Click on the below
to get the latest research data with forecasts for the years 2025 to 2030,
including market size, industry trends, and competitive analysis. It wouldn’t
take long for the team to deliver the most recent version of the report.”
Download a sample PDF of this
report to gain insights into the complete report structure : https://www.marknteladvisors.com/query/request-sample/recombinant-proteins-market.html
What are the major Driver
the Global Recombinant Proteins Market?
The Growing Prevalence of Chronic Diseases Driving
Market Growth – The
increasing occurrence of conditions like cerebral apoplexy, multiple sclerosis,
neutropenia, thrombocytopenia, etc., has been driving the need for recombinant
protein drugs. Additionally, treatment methods such as cancer therapy,
mammalian cell culture, recombinant protein western blot, recombinant DNA,
animal cell culture, glycosylation, biotherapeutics, and bioengineering are
witnessing heightened demand, contributing significantly to overall market growth
worldwide. In addition, one of the major chronic diseases witnessing rapid
growth is cancer. For instance,
- In 2022, according to the American Cancer
Society's 2022 statistics, approximately 1,918,030 new cancer cases were
estimated in the United States alone for the year.
These increasing occurrences
of illnesses among the inhabitants are resulting in the shift towards
innovative health treatments. As a result, several non-government organizations
are increasingly funding the pharma & bio-pharma companies to develop
highly effective drugs. The continuous research & development of
high-efficacy drugs would continue to elevate the requirement for recombinant
proteins, uplifting the Global Recombinant Proteins Market in the forecast
period.
Global Recombinant Proteins Market
Segmentation
The Global
Recombinant Proteins Market analysis of MarkNtel Advisors explores the industry
by emphasizing the growth parameters and categorizes including geographical
segmentation, to offer a comprehensive understanding of the market dynamic. The
further bifurcations are as follows:
- By Product
- Growth Factors and Cytokines- Market
Size & Forecast 2019-2030F, USD Billion
- Epidermal Growth Factor (EGF)- Market
Size & Forecast 2019-2030F, USD Billion
- Platelet-Derived Growth Factor (PDGF)-
Market Size & Forecast 2019-2030F, USD Billion
- Fibroblast Growth Factor (FGF)- Market
Size & Forecast 2019-2030F, USD Billion
- Interferons- Market Size &
Forecast 2019-2030F, USD Billion
- Interleukins- Market Size &
Forecast 2019-2030F, USD Billion
- Others (Vascular Endothelial Growth
Factor (VEGF), Transforming Growth Factor-Beta (TGF-β), etc.)
- Antibodies- Market Size & Forecast
2019-2030F, USD Billion
- Immune Checkpoint Proteins- Market Size
& Forecast 2019-2030F, USD Billion
- Structural Proteins- Market Size &
Forecast 2019-2030F, USD Billion
- Enzymes- Market Size & Forecast
2019-2030F, USD Billion
- Kinases- Market Size & Forecast
2019-2030F, USD Billion
- Hydrolase- Market Size & Forecast
2019-2030F, USD Billion
- Others (Proteases, Lipases, etc.)-
Market Size & Forecast 2019-2030F, USD Billion
- Recombinant Regulatory Proteins- Market
Size & Forecast 2019-2030F, USD Billion
- Hormones- Market Size & Forecast
2019-2030F, USD Billion
- Others (Membrane Proteins, Adhesion
Molecules & Receptors, etc.)- Market Size & Forecast 2019-2030F,
USD Billion
- By Host Cells
- Mammalian Cells- Market Size &
Forecast 2019-2030F, USD Billion
- Insect Cells- Market Size &
Forecast 2019-2030F, USD Billion
- Yeast & Fungi- Market Size &
Forecast 2019-2030F, USD Billion
- Bacterial Cells- Market Size &
Forecast 2019-2030F, USD Billion
- Others- Market Size & Forecast
2019-2030F, USD Billion
- By Application
- Therapeutics- Market Size &
Forecast 2019-2030F, USD Billion
- Biologics- Market Size & Forecast
2019-2030F, USD Billion
- Vaccines- Market Size & Forecast
2019-2030F, USD Billion
- Cell & Gene Therapies- Market Size
& Forecast 2019-2030F, USD Billion
- Others (Immunotherapy, Regenerative
Medicine, etc.) - Market Size & Forecast 2019-2030F, USD Billion
- Research & Development- Market Size
& Forecast 2019-2030F, USD Billion
- Diagnostics- Market Size & Forecast
2019-2030F, USD Billion
- Biotechnology- Market Size &
Forecast 2019-2030F, USD Billion
- Others (Industrial, Cosmetics &
Personal Care, etc.) - Market Size & Forecast 2019-2030F, USD Billion
- By End Users
- Pharmaceutical & Biopharmaceutical
Companies- Market Size & Forecast 2019-2030F, USD Billion
- Research Institutes and Academic
Institutions - Market Size & Forecast 2019-2030F, USD Billion
- Diagnostic Laboratories- Market Size
& Forecast 2019-2030F, USD Billion
- Others (Contract Research Organizations
(CROs), Biotechnology Companies, etc.)- Market Size & Forecast
2019-2030F, USD Billion
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
As per the regional aspect, the Global Recombinant Proteins Market is expected to be dominated by the North America by capturing the potential market share.
Explore further
details about this research report-
https://www.marknteladvisors.com/research-library/recombinant-proteins-market.html
Top
Companies in the Global Recombinant Proteins Market
Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad
Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech
Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell
Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc.,
Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies,
Inc., Others
Global Recombinant
Proteins Industry Recent Development
- 2024: GenScript Biotech Corporation recently unveiled its latest AI innovations, including GenSmart™ Codon Optimization, a free online tool enhancing gene sequence design for improved expression across various host organisms, particularly focusing on recombinant protein production.
- 2024: Merck KGaA has announced a substantial investment of
over USD 320.8 million in a new Life Science Research Center at its global
headquarters in Darmstadt, Germany.
Why Markntel Advisor Report?
Well-known business
Prospects: Our accurate analysis market research report serves as a treasure
map for discovering potential markets and novel product avenues. Additionally,
it facilitates comparisons of products and services.
Thoughtful Customer
Insights: A market report provides the marketing department with an in-depth
understanding of customer requirements and desires. This information is bound
to enhance products, adjust pricing, and refine advertising strategies.
Empowering Data-Backed
Judgement: Our comprehensive Market research encompasses a wide spectrum of
activities, including precise market sizing, detailed segment analysis,
accurate demand forecasting, competitor identification, and meticulous pricing
trend monitoring.
Other reports:
Need
personalized insights? Click here to customize this report-
https://www.marknteladvisors.com/query/request-customization/recombinant-proteins-market.html
MarkNtel
Advisors
Call- +1 628 895 8081, +91 120 4278433
Email
- sales@marknteladvisors.com
Corporate
Office: Office No.109, H-159, Sector 63, Noida, Uttar
Pradesh - 201301, India
Comments
Post a Comment